SPONSOR
National University Hospital, Singapore
Total Trials
11
Recruiting
11
Phases
Phase 1, Phase 2, Phase 1, Phase 2
Conditions studied: Hepatocellular CarcinomaChemotherapy-induced Peripheral NeuropathyStrokeGlioma, AstrocyticBreast CancerLung CancerLung NeoplasmsEarly Lung Cancer DetectionCancer ScreeningHigh-Risk Populations
National University Hospital, Singapore is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Hepatocellular Carcinoma, Chemotherapy-induced Peripheral Neuropathy, Stroke, Glioma, Astrocytic.
The trial portfolio spans Phase 1, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National University Hospital, Singapore
How many clinical trials has National University Hospital, Singapore sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by National University Hospital, Singapore, of which 11 are actively recruiting participants. These trials cover conditions including Hepatocellular Carcinoma, Chemotherapy-induced Peripheral Neuropathy, Stroke. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National University Hospital, Singapore research focus on?
National University Hospital, Singapore clinical trials span Hepatocellular Carcinoma, Chemotherapy-induced Peripheral Neuropathy, Stroke, Glioma, Astrocytic, Breast Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National University Hospital, Singapore clinical trial?
To participate in a National University Hospital, Singapore trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National University Hospital, Singapore trials with current recruitment status updated daily.
Clinical Trials by National University Hospital, Singapore
NCT05687747 Phase 1
Recruiting
Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma
Hepatocellular Carcinoma
NCT05606068
Recruiting
A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy - Expansion Study
Chemotherapy-induced Peripheral Neuropathy
NCT07786649
Recruiting
Evaluating Different Protocols of Non-invasive Brain Stimulation (NIBS) in Stroke Rehabilitation
Stroke
NCT05532397
Recruiting
Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma
Glioma, Astrocytic
NCT05181033 Phase 2
Recruiting
Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor
Breast Cancer
NCT07358715
Recruiting
Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals
Lung Cancer
NCT05035745 Phase 1, Phase 2
Recruiting
Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)
Advanced Refractory Solid Tumors
NCT06653270
Recruiting
Virtual Reality Birth Simulator
Medical Education
NCT06744764
Recruiting
Pulsed Electromagnetic Fields in Preventing Physical Deconditioning in Patients Undergoing Prolonged Hospitalization
Haematological Cancer
NCT06336395 Phase 2
Recruiting
Ma-Spore ALL 2020 Study
B Lymphoblastic Leukemia
NCT07242742
Recruiting
Effectiveness of Pulpotomy vs. Root Canal Treatment in Extremely Deep Caries
Extremely Deep Caries
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology